Sub-Community 于重元 [19/19] 劉柯俊 [85/98] 劉滄梧 [119/125] 劉界元(2003-2010) [3/3] 夏和雄(1996-2012) [26/31] 夏興國 [51/54] 姜乃榕 [82/94] 常慧如 [39/44] 張俊彥 [234/254] 張光裕 [69/79] 張憶壽 [104/107] 張文祥 [52/53] 張書銘 [89/91] 彭汪嘉康(1996-2007) [120/126] 施能耀 [37/43] 李家惠 [29/29] 李岳倫 [48/49] 林素芳 [32/32] 楊奕馨 [41/42] 江士昇 [88/90] 沈哲宏 [14/16] 洪文俊 [88/88] 莊雙恩 [82/91] 蔡坤志 [32/34] 蔡慧珍 [67/72] 蘇勇曄 [40/40] 蘇振良 [24/25] 郭靜娟 [71/76] 陳尚鴻 [45/48] 陳振陽 [72/72] 陳立宗 [444/511] 陳美霞(2002-2009) [1/1] 陳詩政 [2/2] 陳雅雯 [38/39] 黃智興 [55/55] 黃道揚 [26/26] 丁兆治(2000-2004) [5/5] 其他 [465/472] 劉敏(1996-2007) [60/62] 劉玫英(2004-2006) [2/2] 吳成文(1996-2008) [53/55] 曾思文(1997-2007) [4/4] 李冠德(1997-2004) [4/6] 林景太(1999-2007) [5/5] 楊文光(1996-1999) [21/21] 王全正(1996-2003) [4/4] 莊聲宏(1997-2004) [11/11] 詹宗晃(2000-2008) [2/2] 賴基銘(2004-2008) [41/47] 阮麗蓉(2000-2006) [6/7] 陳俊叡(2003-2007) [6/6] 馬彥英(1997-1999) [1/1] 黃奇英(2005-2007) [9/10] Siblings 分子與基因醫學研究所 [924/967] 生技與藥物研究所 [833/1011] 生醫工程與奈米醫學研究所 [1221/1341] 免疫醫學研究中心 [226/238] 神經及精神醫學研究中心 [787/809] 細胞及系統醫學研究所 [758/818] 感染症與疫苗研究所 [1544/1621] 群體健康科學研究所 [2881/3011] 國家環境醫學研究所 [1563/1594] 國家蚊媒傳染病防治研究中心 [103/105] 高齡醫學暨健康福祉研究中心 [223/231] 論壇 [2/2] 生醫資源中心 [7/7] 研究生培育合作學程 [190/194] 核心儀器設施中心 [9/9] 病理核心實驗室 [14/14] 實驗動物中心 [9/9] 行政管理部門 [18/18] Community Statistics 近3年內發表的文件:338(14.01%) 含全文筆數:2253(93.41%) 文件下載次數統計 下載大於0次:2253(100.00%) 下載大於100次:2253(100.00%) 檔案下載總次數:1618764(28.86%) 最後更新時間: 2024-12-04 17:40 Top Upload Loading... Top Download Loading... Recent Submissions Gastrointestinal comorbidities in p... Polygenic risk score and lung adeno... Cooperative participation of CagA a... Pathological response following neo... Registry of genetic alterations of ... Activated single nucleotide mismatc... Taiwan nationwide study of first-li... The effectiveness of virtual passpo... Special Issue "Bioinformatics ... Evaluating a natural language proce...

Jump to a point in the index: (Choose year) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 791-800 of 2412. (242 Page(s) Totally) << < 75 76 77 78 79 80 81 82 83 84 > >> View [10|25|50] records per page

Date	Title	Relation
2018-06	Differentiation of mesenchymal stem cells from human induced pluripotent stem cells results in downregulation of c-Myc and DNA replication pathways with immunomodulation toward CD4 and CD8 cells	Stem Cells. 2018 Jun;36(6):903-914.
2018-06	An epigenome-wide study of cord blood DNA methylations in relation to prenatal perfluoroalkyl substance exposure: The Hokkaido study	Environment International. 2018 Jun;115:21-28.
2018-06	Role of lncRNAs in the cancer development and progression and their regulation by various phytochemicals	Biomedicine and Pharmacotherapy. 2018 Jun;102:242-248.
2018-06	Patterns of interindividual variability in the antibody repertoire targeting proteins across the Epstein-Barr virus proteome	Journal of Infectious Diseases. 2018 Jun;217(12):1923-1931.
2018-06	The interplay between oral microbiome, lifestyle factors, and genetic polymorphisms in the risk of oral squamous cell carcinoma	Carcinogenesis. 2018 Jun;39(6):778-787.
2018-06	Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma	Annals of Oncology. 2018 Jun;29(6):1402-1408.
2018-06	The effect of best response to prior anticancer therapy on efficacy outcomes in the napoli-1 trial of patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) previously treated with gemcitabine-based therapy	Annals of Oncology. 2018 Jun;29(Suppl. 5):Meeting Abstract P-152.
2018-06	Decreased appetite (DA) at baseline impacts prognosis in the NAPOLI-1 phase 3 study in metastatic pancreatic ductal adenocarcinoma (mPDAC)	Annals of Oncology. 2018 Jun;29(Suppl. 5):Meeting Abstract P-153.
2018-06	Prognostic effect of primary tumor location in the NAPOLI-1 phase 3 study in metastatic pancreatic ductal adenocarcinoma (mPDAC)	Annals of Oncology. 2018 Jun;29(Suppl. 5):Meeting Abstract P-150.
2018-06	Selected subgroup analyses of liposomal irinotecan (nal-IRI) in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) in the global NAPOLI-1 phase III trial	Annals of Oncology. 2018 Jun;29(Suppl. 5):Meeting Abstract O-004.

Showing items 791-800 of 2412. (242 Page(s) Totally) << < 75 76 77 78 79 80 81 82 83 84 > >> View [10|25|50] records per page